 |
|
|
|
 |
|
|
| Article 1 to 10 out of 14 concerning Helmholtz-Zentrum für Infektionsforschung GmbH
|
-
Metabolism, Maths, Medicine: If Bacteria Were Calculable
(18 Feb 2008)
For the first time, researchers at the Helmholtz Centre for Infection Research (HZI) have produced a comprehensive model of the metabolic processes of the bacterium Pseudomonas aeruginosa. With this, the basis is created for the development of ...
-
Ascenion Mediates License Agreement on Novel Vaccine Adjuvant between HZI and AmVac
(14 Dec 2007)
The Helmholtz Centre for Infection Research in Braunschweig (HZI) and AmVac AG entered into a license agreement providing AmVac with exclusive rights to develop and commercialize a synthetic lipopeptide called MALP-2 and its derivatives as vaccine ...
-
Iron Rivets in Cellular Building Blocks
(23 Jan 2007)
Microorganisms Living in Sulfuric Acid have a Unique Biochemical Machinery
The fact that Ferroplasma acidiphilum, a single-celled organism lacking a protective cell wall, is capable of living in sulfuric acid is already extraordinary. But what really makes the microbe unique is its unusual relationship to iron. Researchers ...
-
Shampoo consuming Bacteria
(23 May 2006)
Why Pseudomonas is able to withstand attacks of hygiene
The pernicious bacterium Pseudomonas aeruginosa is able to persist in the human respiratory tract for long periods of time and also frequently causes acute infections in open wounds especially following open surgery. It is able to resist common ...
-
A Shot to Stop Diabetes in Mice
(06 Dec 2005)
Intervention in Immune Regulation Can Prevent Onset of Type-1 Diabetes
Some forms of diabetes could feasibly be prevented. Scientists at the German Research Centre for Biotechnology (GBF) in Braunschweig recently were able to do just that in experiments with mice. Animals with a congenital susceptibility for Type-1 ...
-
ALAS, scientists at the GBF reveal the structure of a life-sustaining enzyme
(26 Sep 2005)
Scientists of the GBF and the Technical University in Braunschweig have resolved the 3-dimensional structure of the enzyme that catalyses the first step in the synthesis of heme. "ALAS (short for '5-aminolevulinate synthase') was the last remaining ...
-
Quick Test for Polluted Environments
(24 Jan 2005)
The "Biotool" project seeks to use bacterial marker molecules for predictions
Bacteria usually rapidly adapt to environmental pollution. They generate specific proteins - biomolecules - that break down pollutants and help them to survive under otherwise adverse conditions. A more precise study of these molecules has now been ...
-
Chronic Illness from Faulty Friends
(05 Jan 2005)
Immune cells can trigger severe pneumonia
A new study has found that malfunctioning immune cells can be the cause of severe pneumonia. This discovery was made by scientists working at the German Research Centre for Biotechnology (GBF) in Braunschweig. In the latest issue of the American ...
-
When Tooth Decay Becomes Fatal
(26 Nov 2004)
Researchers to study role of oral streptococci in serious diseases
Oral streptococci, bacteria living in the human mouth, are capable of causing much more than just dental caries. Serious diseases such as cardiac valve inflammation have also been shown to be triggered by this bacterium. A new research project, ...
-
Scientists study innovative DNA transport element
(11 Nov 2004)
Treating genetic diseases by introducing functional genes into the human organism: researchers from three European countries are aiming for a breakthrough in this process, known as gene therapy, using a new methodology. The network of scientists, ...
Additional information
Helmholtz-Zentrum für Infektionsforschung GmbH
Braunschweig, Germany
Company
|
|
|
|
|
|
Top
